News

An open letter from our CEO, Joerg Ahlgrimm to SK pharmteco Customers SK pharmteco’s mission is to improve patient outcomes and save lives by partnering with our customers to produce and deliver life changing therapies through manufacturing and technical excellence, a positive and adaptable workforce, and an intense focus on safety, quality, and innovation. Our […]

We’re in the news… check out the latest issue of #chemicalsknowledgehub featuring an article focused on our innovative skids for small scale #continuousflowprocessing developed by teams at our #RanchoCordova site, led by Dr William DuBay VP R&D #SKpharmteco, and AMPAC Fine Chemicals’ Dr John Jacobsen Executive Director R&D and Dr Ryan Woods Senior Manager R&D

We’re in the news… click the link to read the full article https://lnkd.in/evaqHhDW

We’re in the news…click the link to read the full article https://biomag1.com/sk-pharmteco-appoints-joerg-ahlgrimm-as-ceo/

Exclusive: SK Pharmteco’s French CDMO to complete construction of new plant in Q1 2023 Yposkesi CEO Alain Lamproye says 2nd plant expected to begin operation at start of 2024. FRANKFURT, Germany — Yposkesi, SK Pharmteco’s French contract development and manufacturing organization specialized in cell and gene therapy, is expecting to complete the construction of its

SK pharmteco appoints Joerg Ahlgrimm as CEO November 1, 2022 – SK pharmteco, a global contract development and manufacturing organization (CDMO) serving the pharmaceutical industry, today announced that Joerg Ahlgrimm will be appointed as the Chief Executive Officer. Ahlgrimm will assume the global leadership of the company and spearhead its next phase of innovation and

We’re in the news…Business Korea ‘SK Inc. Expanding into CGT CDMO Business’ click the link to read the full article https://lnkd.in/ecpPw8Z9

Press Release: Immediate Release Date: 26 October 2022 Leaders in Continuous Flow Processing innovate to increase capability for small scale manufacture